首页> 外国专利> MONOCLONAL ANTIBODY WHICH DISTINGUISHES HELPER INDUCER AND SUPPRESSOR INDUCER CD4+ LYMPHOCYTES

MONOCLONAL ANTIBODY WHICH DISTINGUISHES HELPER INDUCER AND SUPPRESSOR INDUCER CD4+ LYMPHOCYTES

机译:单克隆抗体可区分肝细胞诱导剂和抑制因子CD4 +淋巴细胞

摘要

A monoclonal antibody which binds preferentially to a subset of the human CD4+ lymphocyte population whereby topositively and precisely distinguish between helper-inducer and supressor-inducer cells in the CD4+ cell population. Themonoclonal antibody recognizes a novel antigen on the CD4+ lymphocytes by means of which it can bind CD4+ cells which expressthe antigen on the surface of CD4+ cells. The CD4+ subset cell population to which this antibody preferentially binds is theCD4+ helper-inducer population. This selectivity of the monoclonal antibody enables cell sorting, diagnostic and possibletherapeutic applications thereof to be realized. The monoclonal antibody also reacts with CD8 cells, B cells and macrophages.
机译:一种单克隆抗体,优先与人CD4 +淋巴细胞群的一部分结合,从而准确,准确地区分CD4 +细胞群体中的辅助诱导细胞和抑制诱导细胞。的单克隆抗体识别CD4 +淋巴细胞上的一种新抗原,通过它可以结合表达CD4 +细胞表面的抗原。该抗体优先结合的CD4 +亚群细胞群是CD4 +辅助诱导人群。单克隆抗体的这种选择性使细胞分选,诊断和可能其治疗应用得以实现。单克隆抗体还与CD8细胞,B细胞和巨噬细胞反应。

著录项

  • 公开/公告号CA2069501C

    专利类型

  • 公开/公告日1998-09-01

    原文格式PDF

  • 申请/专利权人 DANA-FARBER CANCER INSTITUTE;

    申请/专利号CA19902069501

  • 发明设计人 MORIMOTO CHIKAO;SCHLOSSMAN STUART F.;

    申请日1990-11-15

  • 分类号C12N5/18;A61K47/48;A61K49/00;A61K51/10;C07K16/28;G01N33/554;G01N33/577;

  • 国家 CA

  • 入库时间 2022-08-22 02:54:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号